Home / SUCLG1 Knockout Cell Lines

SUCLG1 Knockout Cell Lines

Gene: SUCLG1

Official Full Name: succinate-CoA ligase GDP/ADP-forming subunit alphaprovided by HGNC

Gene Summary: This gene encodes the alpha subunit of the heterodimeric enzyme succinate coenzyme A ligase. This enzyme is targeted to the mitochondria and catalyzes the conversion of succinyl CoA and ADP or GDP to succinate and ATP or GTP. Mutations in this gene are the cause of the metabolic disorder fatal infantile lactic acidosis and mitochondrial DNA depletion. [provided by RefSeq, Feb 2010]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00287 SUCLG1 Knockout cell line (HCT 116) Human SUCLG1 1:2~1:4 Negative Online Inquiry
KO00452 SUCLG1 Knockout cell line (HEK293) Human SUCLG1 1:3~1:6 Negative Online Inquiry
KO33804 SUCLG1 Knockout cell line (HeLa) Human SUCLG1 1:3~1:6 Negative Online Inquiry
KO33805 SUCLG1 Knockout cell line (HCT 116) Human SUCLG1 1:2~1:4 Negative Online Inquiry
KO33806 SUCLG1 Knockout cell line (A549) Human SUCLG1 1:3~1:4 Negative Online Inquiry

Background

SUCLG1 Gene Knockout Cell Lines are genetically engineered cell lines where the SUCLG1 gene, which encodes the enzyme succinyl-CoA ligase, has been effectively knocked out. This innovative product allows researchers to explore the pathogenic mechanisms linked to mitochondrial dysfunction and metabolic disorders. By creating a model that lacks the SUCLG1 gene, researchers can study the effects of its absence on cellular metabolism, energy production, and overall cellular health, particularly in relation to the Krebs cycle and ATP generation.

The primary mechanism of action involves the disruption of normal cellular respiration associated with the energy conversion processes within mitochondria. The SUCLG1 enzyme plays a vital role in catalyzing the synthesis of succinyl-CoA, a critical intermediate in the Krebs cycle. The knockout of this gene leads to a significant decrease in succinyl-CoA levels, providing insights into energy metabolism alterations and the potential compensatory mechanisms employed by the cell. This unique cellular model makes it possible to investigate how defects in this pathway can lead to mitochondrial diseases or other metabolic disorders.

From a scientific perspective, SUCLG1 Gene Knockout Cell Lines are invaluable in both research and clinical settings. Researchers can utilize these cell lines to understand disease mechanisms, screen for therapeutic compounds, or test metabolic interventions that report back on the effects of metabolic perturbations. Furthermore, the availability of these knockout lines accelerates the pace of discovery in the field of mitochondrial biology, offering a tailored approach for developing targeted therapies.

One key advantage of our SUCLG1 Gene Knockout Cell Lines lies in their specificity and the reliability of results, as they provide a consistent genetic background for experimentation. Compared to other models, such as pharmacological inhibitors or transient knockdowns, these stable cell lines offer long-term reproducibility and a streamlined workflow for researchers.

This product is essential for any laboratory focused on metabolic research, mitochondrial function, or therapeutic development, allowing users to gain unique insights into their investigations. The expertise behind our product is rooted in a commitment to advancing biotechnological innovations and providing top-tier research tools. As leaders in the field, we understand the challenges faced by researchers and are dedicated to supplying superior solutions that meet your scientific needs.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.